e6vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of November, 2009
Commission File Number 1-14840
AMDOCS LIMITED
Suite 5, Tower Hill House Le Bordage
St. Peter Port, Island of Guernsey, GY1 3QT Channel Islands
Amdocs, Inc.
1390 Timberlake Manor Parkway, Chesterfield, Missouri 63017
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
FORM 20-F þ     FORM 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to rule 12g3-2(b) under the Securities Exchange Act of 1934.
YES o     NO þ
 
 

 


TABLE OF CONTENTS

SIGNATURES
EXHIBIT INDEX
EX-99.1


Table of Contents

     On November 4, 2009, Amdocs Limited (“Amdocs”) issued a press release announcing financial results for the quarter and fiscal year ended September 30, 2009. A copy of the press release is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K.
     The information in this Form 6-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

 


Table of Contents

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
         
  AMDOCS LIMITED
 
 
  /s/ Thomas G. O’Brien    
  Thomas G. O’Brien   
  Treasurer and Secretary
Authorized U.S. Representative 
 
 
Date: November 4, 2009

 


Table of Contents

EXHIBIT INDEX
     
EXHIBIT NO.   DESCRIPTION
99.1
  Amdocs Limited Press Release dated November 4, 2009.

 

exv99w1
Exhibit 99.1
     
PRESS RELEASE   (AMDOCS LOGO)
Amdocs Limited Reports Quarterly Revenue of $707 Million,
Up Sequentially and Above Guidance
Key highlights:
    Fourth quarter revenue of $707 million, above the $670-$690 million guidance range
 
    Fourth quarter non-GAAP operating income of $128 million; non-GAAP operating margin of 18.1%; GAAP operating income of $97 million
 
    Fourth quarter diluted non-GAAP EPS of $0.53, excluding amortization of purchased intangible assets and equity-based compensation expense, net of related tax effects
 
    Diluted GAAP EPS of $0.42 for the fourth quarter
 
    Free cash flow of $166 million for the fourth quarter
 
    12-month backlog of $2.385 billion at the end of the fourth quarter
 
    First quarter fiscal 2010 guidance: Expected revenue of approximately $705-$725 million and diluted non-GAAP EPS of $0.51-$0.55, excluding acquisition-related costs and approximately $0.04-$0.05 per share of equity-based compensation expense, net of related tax effects. Diluted GAAP EPS is expected to be approximately $0.38-$0.44
ST. LOUIS – November 4, 2009 – Amdocs Limited (NYSE: DOX) today reported that for its fiscal fourth quarter ended September 30, 2009, revenue was $707.4 million, a decrease of 14.3% from last year’s fourth quarter and up 2.5% sequentially. Net income on a non-GAAP basis was $109.2 million, or $0.53 per diluted share, compared to non-GAAP net income of $117.2 million, or $0.54 per diluted share, in the fourth quarter of fiscal 2008. Non-GAAP net income excludes amortization of purchased intangible assets and equity-based compensation expenses of $23.4 million, net of related tax effects, in the fourth quarter of fiscal 2009 and excludes such amortization, equity-based compensation expenses and restructuring charges of $34.5 million, net of related tax effects, in the fourth quarter of fiscal 2008. The Company’s GAAP net income for the fourth quarter of fiscal 2009 was $85.8 million, or $0.42 per diluted

 


 

share, compared to GAAP net income of $82.7 million, or $0.38 per diluted share, in the prior year’s fourth quarter.
“After experiencing a challenging fiscal year, we are pleased that our fourth quarter results demonstrated stronger-than-expected performance across our four key financial metrics: revenue, profitability, earnings and free cash flow. We believe this reflects positively on the value of Amdocs’ market leading offerings and strategic position against the backdrop of steadying economic conditions. While indicators are still mixed across our market and the global economy, we are cautiously optimistic that our business is stabilizing to slightly improving, as reflected in our fiscal first quarter guidance for 2010,” said Dov Baharav, chief executive officer of Amdocs Management Limited.
Baharav continued, “Reflecting on our relative successes in 2009, we experienced rising interest and strong signings in managed services which we believe addresses the communications industry’s need to streamline cost structures, while concurrently offering the option to modernize systems. Additionally, we performed very well in cable and satellite in a tough economy, and we validated our market position by establishing and expanding important relationships with leading operators. We expect these two growth drivers – managed services and cable and satellite – to continue to perform well and provide a strong foundation for our results again in 2010. On the other hand, our project-oriented activities contracted in 2009 as they naturally reacted more sharply to deteriorating economic conditions. We believe, in aggregate, our project-oriented revenue is showing early signs of stabilization; however, decision cycles remain extended and results may still vary quarter to quarter in individual product areas and geographies.”
Baharav concluded, “Lastly, we believe we have made the right investments to drive our future long-term growth. Over the course of the recession, we have deepened our relationships with key customers, led the industry in R&D investment, and continued to streamline our cost structure. As a result, we truly believe we are emerging from the global economic crisis in a stronger competitive position than we entered.”

 


 

Free cash flow was $166 million for the quarter, comprised of cash flow from operations of $184 million less approximately $18 million in net capital expenditures and other.
Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $2.385 billion at the end of the fourth quarter of fiscal 2009.
Financial Outlook
Amdocs expects that revenue for the first quarter of fiscal 2010 will be approximately $705-$725 million. Diluted earnings per share on a non-GAAP basis for the first quarter are expected to be $0.51-$0.55, excluding acquisition-related costs and approximately $0.04-$0.05 per share of equity-based compensation expense, net of related tax effects. Amdocs estimates GAAP diluted earnings per share for the first quarter will be $0.38-$0.44.
Fiscal Year 2009 Results
For the fiscal year ended September 30, 2009, revenue decreased by 9.5% to $2.863 billion. Fiscal 2009 net income on a non-GAAP basis was $438.9 million, or $2.12 per diluted share (excluding acquisition-related costs, which include amortization of purchased intangible assets and in-process research and development write-off, and excluding restructuring charges and equity-based compensation expense, net of related tax effects, of $112.7 million), compared to non-GAAP net income of $499.6 million, or $2.29 per diluted share, in fiscal 2008 (excluding acquisition-related costs, which include amortization of purchased intangible assets and in-process research and development write-off, and excluding restructuring charges and equity-based compensation expense, net of related tax effects, of $120.7 million). The Company’s GAAP net income in fiscal 2009 was $326.2 million, or $1.58 per diluted share, compared to GAAP net income of $378.9 million, or $1.74 per diluted share, in fiscal 2008.
Amdocs will host a conference call on November 4, 2009 at 5 p.m. Eastern Time to discuss the Company’s fourth quarter results. The call will be carried live on the Internet via the Amdocs website, www.amdocs.com.

 


 

Non-GAAP Financial Measures
This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes and non-GAAP net income. These non-GAAP measures exclude the following items:
    amortization of purchased intangible assets;
 
    in-process research and development write-off;
 
    restructuring charges;
 
    equity-based compensation expense; and
 
    tax effects related to the above.
These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures.
Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes and non-GAAP net income, when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

 


 

For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased intangible assets, in-process research and development write-off, restructuring charges, equity-based compensation expense, and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these non-cash expenses in reviewing its results and those of its competitors, because the amounts of the expenses between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the expenses.
Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of service, research and development, selling, general and administrative, operating income, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments.
Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.
About Amdocs
Amdocs is the market leader in customer experience systems innovation, enabling world-leading service providers to deliver an integrated, innovative and the intentional customer experienceTM – at every point of service. Amdocs provides solutions that deliver customer experience excellence, combining the software, service and expertise to help its customers execute their strategies and achieve service, operational and financial excellence. A global company with revenue of $2.86 billion in fiscal 2009, Amdocs has approximately 17,000 employees and serves customers in more than 60 countries around the world. For more information, visit Amdocs at www.amdocs.com.
This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995,

 


 

including statements about Amdocs growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs ability to grow in the business markets that it serves, Amdocs ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company’s products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in the Company’s filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2008 filed on December 8, 2008 and in our quarterly 6-Ks furnished on February 9, 2009, May 12, 2009 and August 10, 2009.
Contact:
Elizabeth Grausam
Director of Investor Relations
Amdocs Limited
314-212-8328
E-mail: dox_info@amdocs.com

 


 

AMDOCS LIMITED
Consolidated Statements of Income
(in thousands, except per share data)
                                 
    Three months ended     Twelve months ended  
    September 30,     September 30,  
    2009     2008     2009     2008  
Revenue:
                               
License
  $ 27,267     $ 41,917     $ 135,146     $ 135,487  
Service
    680,152       783,360       2,727,461       3,026,609  
 
                       
 
    707,419       825,277       2,862,607       3,162,096  
 
                               
Operating expenses:
                               
Cost of license
    589       462       2,686       2,729  
Cost of service
    450,122       530,428       1,831,947       2,023,562  
Research and development
    50,274       57,252       210,387       225,492  
Selling, general and administrative
    88,030       103,171       344,335       404,134  
Amortization of purchased intangible assets
    21,559       20,385       85,153       86,687  
Restructuring charges and in-process research and development (1)
          12,116       20,780       13,896  
 
                       
 
    610,574       723,814       2,495,288       2,756,500  
 
                       
Operating income
    96,845       101,463       367,319       405,596  
 
                               
Interest (expense) income and other, net
    (151 )     (11,842 )     (1,165 )     11,955  
 
                       
Income before income taxes
    96,694       89,621       366,154       417,551  
 
                               
Income taxes
    10,943       6,910       39,978       38,645  
 
                         
Net income
  $ 85,751     $ 82,711     $ 326,176     $ 378,906  
 
                         
Basic earnings per share
  $ 0.42     $ 0.40     $ 1.61     $ 1.83  
 
                       
Diluted earnings per share (2)
  $ 0.42     $ 0.38     $ 1.58     $ 1.74  
 
                       
Basic weighted average number of shares outstanding
    203,587       205,164       202,867       206,590  
 
                       
Diluted weighted average number of shares outstanding
    204,883       217,479       207,606       219,606  
 
                       
 
(1)   Restructuring charges and in-process research and development for the twelve months ended September 30, 2009 and 2008 include restructuring charges of $15,140 and $12,116 and in-process research and development of $5,640 and $1,780, respectively.
 
(2)   To reflect the impact of assumed conversion of the convertible notes, $0 and $1,486, representing interest expense and amortization of issuance costs, were added back to net income for the three and twelve months ended September 30, 2009, respectively, and $985 and $3,940 were added back to net income for the three and twelve months ended September 30, 2008, respectively, for the purpose of computing diluted earnings per share.

 


 

AMDOCS LIMITED
Selected Financial Metrics
(in thousands, except per share data)
                                 
    Three months ended   Twelve months ended
    September 30,   September 30,
    2009   2008   2009   2008
Revenue
  $ 707,419     $ 825,277     $ 2,862,607     $ 3,162,096  
 
                               
Non-GAAP operating income
    127,984       147,744       516,163       563,669  
 
                               
Non-GAAP net income
    109,198       117,208       438,878       499,608  
 
                               
Non-GAAP diluted earnings per share (1)
  $ 0.53     $ 0.54     $ 2.12     $ 2.29  
 
                               
Diluted weighted average number of shares outstanding
    204,883       217,479       207,606       219,606  
 
(1)   To reflect the impact of assumed conversion of the convertible notes, $0 and $1,486, representing interest expense and amortization of issuance costs, were added back to net income for the three and twelve months ended September 30, 2009, respectively, and $985 and $3,940 were added back to net income for the three and twelve months ended September 30, 2008, respectively, for the purpose of computing diluted earnings per share.

 


 

AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
(in thousands)
                                         
    Three months ended
    September 30, 2009
            Reconciliation items    
            Amortization            
            of purchased   Equity based        
            intangible   compensation        
    GAAP   assets   expense   Tax effect   Non-GAAP
     
Operating expenses:
                                       
Cost of license
  $ 589     $     $     $     $ 589  
Cost of service
    450,122             (4,957 )           445,165  
Research and development
    50,274             (972 )           49,302  
Selling, general and administrative
    88,030             (3,651 )           84,379  
Amortization of purchased intangible assets
    21,559       (21,559 )                  
     
Total operating expenses
    610,574       (21,559 )     (9,580 )         $ 579,435  
     
 
                                       
     
Operating income
    96,845       21,559       9,580             127,984  
     
 
                                       
     
Income taxes
    10,943                   7,692       18,635  
     
 
                                       
     
Net income
  $ 85,751     $ 21,559     $ 9,580     $ (7,692 )   $ 109,198  
     
                                                 
    Three months ended
    September 30, 2008
            Reconciliation items    
            Amortization                    
            of purchased           Equity based        
            intangible   Restructuring   compensation        
    GAAP   assets   charges   expense   Tax effect   Non-GAAP
     
Operating expenses:
                                               
Cost of license
  $ 462     $     $     $     $     $ 462  
Cost of service
    530,428                   (5,836 )           524,592  
Research and development
    57,252                   (1,088 )           56,164  
Selling, general and administrative
    103,171                   (6,856 )           96,315  
Amortization of purchased intangible assets
    20,385       (20,385 )                        
Restructuring charges and in-process research and development
    12,116             (12,116 )                  
     
Total operating expenses
    723,814       (20,385 )     (12,116 )     (13,780 )         $ 677,533  
     
 
                                               
     
Operating income
    101,463       20,385       12,116       13,780             147,744  
     
 
                                               
     
Income taxes
    6,910                         11,784       18,694  
     
 
                                               
     
Net income
  $ 82,711     $ 20,385     $ 12,116     $ 13,780     $ (11,784 )   $ 117,208  
     

 


 

AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
(in thousands)
                                                 
    Twelve months ended
    September 30, 2009
            Reconciliation items    
                    Restructuring            
            Amortization   charges and            
            of purchased   in-process   Equity based        
            intangible   research and   compensation        
    GAAP   assets   development   expense   Tax effect   Non-GAAP
     
Operating expenses:
                                               
Cost of license
  $ 2,686     $     $     $     $     $ 2,686  
Cost of service
    1,831,947                   (21,733 )           1,810,214  
Research and development
    210,387                   (4,249 )           206,138  
Selling, general and administrative
    344,335                   (16,929 )           327,406  
Amortization of purchased intangible assets
    85,153       (85,153 )                        
Restructuring charges and in-process research and development
    20,780             (20,780 )                  
     
Total operating expenses
    2,495,288       (85,153 )     (20,780 )     (42,911 )           2,346,444  
     
 
                                               
     
Operating income
    367,319       85,153       20,780       42,911             516,163  
     
 
                                               
     
Income taxes
    39,978                         36,142       76,120  
     
 
                                               
     
Net income
  $ 326,176     $ 85,153     $ 20,780     $ 42,911     $ (36,142 )   $ 438,878  
     
                                                 
    Twelve months ended
    September 30, 2008
            Reconciliation items    
                    Restructuring            
            Amortization of   charges and            
            purchased   in-process   Equity based        
            intangible   research and   compensation        
    GAAP   assets   development   expense   Tax effect   Non-GAAP
     
Operating expenses:
                                               
Cost of license
  $ 2,729     $     $     $     $     $ 2,729  
Cost of service
    2,023,562                   (23,547 )           2,000,015  
Research and development
    225,492                   (4,714 )           220,778  
Selling, general and administrative
    404,134                   (29,229 )           374,905  
Amortization of purchased intangible assets
    86,687       (86,687 )                        
Restructuring charges and in-process research and development
    13,896             (13,896 )                  
     
Total operating expenses
    2,756,500       (86,687 )     (13,896 )     (57,490 )           2,598,427  
     
 
                                               
     
Operating income
    405,596       86,687       13,896       57,490             563,669  
     
 
                                               
     
Income taxes
    38,645                         37,371       76,016  
     
 
                                               
     
Net income
  $ 378,906     $ 86,687     $ 13,896     $ 57,490     $ (37,371 )   $ 499,608  
     

 


 

AMDOCS LIMITED
Condensed Consolidated Balance Sheets
(in thousands)
                 
    As of  
    September 30,     September 30,  
    2009     2008  
ASSETS
               
 
               
Current assets
               
Cash, cash equivalents and short-term interest-bearing investments
  $ 1,173,041     $ 1,244,378  
Accounts receivable, net, including unbilled of $21,749 and $48,264 respectively
    454,965       573,764  
Deferred income taxes and taxes receivable
    117,848       84,515  
Prepaid expenses and other current assets
    126,704       102,930  
 
           
Total current assets
    1,872,558       2,005,587  
 
               
Equipment, vehicles and leasehold improvements, net
    279,659       317,081  
Goodwill and other intangible assets, net
    1,766,761       1,796,922  
Other noncurrent assets
    409,439       459,473  
 
           
Total assets
  $ 4,328,417     $ 4,579,063  
 
           
 
               
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
 
               
Current Liabilities
               
Accounts payable, accruals and other
  $ 415,371     $ 601,945  
Deferred revenue
    186,158       197,851  
Deferred income taxes and taxes payable
    9,338       30,228  
 
           
Total current liabilities
    610,867       830,024  
0.50% Convertible notes
    1,020       450,000  
Noncurrent liabilities and other
    503,477       493,848  
Shareholders’ equity
    3,213,053       2,805,191  
 
           
Total liabilities and shareholders’ equity
  $ 4,328,417     $ 4,579,063  
 
           

 


 

AMDOCS LIMITED
Consolidated Statements of Cash Flows
(in thousands)
                 
    Year ended September 30,  
    2009     2008  
Cash Flow from Operating Activities:
               
Net income
  $ 326,176     $ 378,906  
Reconciliation of net income to net cash provided by operating activities:
               
Depreciation and amortization
    198,119       192,937  
In-process research and development expenses
    5,640       1,780  
Equity-based compensation expense
    42,911       57,490  
Loss (gain) on sale of equipment
    197       (970 )
Deferred income taxes
    16,249       1,111  
Gain on repurchase of convertible notes
    (2,185 )      
Excess tax benefit from equity-based compensation
    (18 )     (211 )
Loss from short-term interest-bearing investments
    4,449       4,945  
Net changes in operating assets and liabilities, net of amounts acquired:
               
Accounts receivable, net
    131,527       (118,291 )
Prepaid expenses and other current assets
    (13,614 )     4,173  
Other noncurrent assets
    (2,690 )     (31,739 )
Accounts payable, accrued expenses and accrued personnel
    (160,321 )     (27,501 )
Deferred revenue
    20,956       28,408  
Income taxes payable, net
    (19,980 )     (26,824 )
Noncurrent liabilities and other
    (28,260 )     18,799  
 
           
Net cash provided by operating activities
    519,156       483,013  
 
           
 
               
Cash Flow from Investing Activities:
               
Proceeds from sale of equipment, vehicles and leasehold improvements
    994       2,655  
Payments for purchase of equipment and leasehold improvements
    (83,325 )     (135,823 )
Proceeds from sale of short-term interest-bearing investments
    1,045,278       708,708  
Purchase of short-term interest-bearing investments
    (963,433 )     (685,873 )
Net cash paid for acquisitions
    (65,890 )     (58,772 )
 
           
Net cash used in investing activities
    (66,376 )     (169,105 )
 
           
 
               
Cash Flow from Financing Activities:
               
Borrowings under long-term financing arrangements
    450,000        
Payments under long-term financing arrangements
    (450,000 )      
Redemption of convertible notes
    (330,780 )     (175 )
Repurchase of convertible notes
    (116,015 )      
Repurchase of shares
    (20,014 )     (247,630 )
Proceeds from employee stock options exercised
    27,893       37,577  
Payments under capital lease and short-term financing arrangements
    (3,970 )     (542 )
Excess tax benefit from equity-based compensation
    18       211  
 
           
Net cash used in financing activities
    (442,868 )     (210,559 )
 
           
 
               
Net increase in cash and cash equivalents
    9,912       103,349  
Cash and cash equivalents at beginning of year
    718,850       615,501  
 
           
Cash and cash equivalents at end of year
  $ 728,762     $ 718,850  
 
           

 


 

AMDOCS LIMITED
Supplementary Information
(in millions)
                                         
    Three months ended  
    September 30,     June 30,     March 31,     December 31,     September 30,  
    2009     2009     2009     2008     2008  
North America
  $ 528.0     $ 527.7     $ 539.8     $ 561.6     $ 558.7  
Europe
    93.0       84.4       105.0       111.4       150.9  
Rest of World
    86.4       78.2       66.3       80.8       115.7  
 
                             
Total Revenue
  $ 707.4     $ 690.3     $ 711.1     $ 753.8     $ 825.3  
 
                             
                                         
    Three months ended  
    September 30,     June 30,     March 31,     December 31,     September 30,  
    2009     2009     2009     2008     2008  
Customer Experience
                                       
Systems
  $ 668.6     $ 647.9     $ 668.0     $ 701.0     $ 756.5  
Directory
    38.8       42.4       43.1       52.8       68.8  
 
                             
Total Revenue
  $ 707.4     $ 690.3     $ 711.1     $ 753.8     $ 825.3  
 
                             
                                         
    As of  
    September 30,     June 30,     March 31,     December 31,     September 30,  
    2009     2009     2009     2008     2008  
12-Month Backlog
  $ 2,385     $ 2,370     $ 2,370     $ 2,400     $ 2,420  
 
                             
# # #